19
Jun
2024

Sinotherapeutics Inc.

Exhibitor at CPHI & PMEC China 2024 stand E3B26a, Finished Dosage
About Us

Sinotherapeutics was founded in 2012, and now listed on China STAR Market. We provide “One-stop” Formulation Development CRO and CDMO services for new drug candidates with established advanced formulation R&D and manufacturing platforms. The headquarter and R&D center is located in Shanghai with well setup for formulation and analytical labs. Our manufacturing site is located in Jiangsu and has been inspected multiple times by US FDA and Chinese NMPA. We have an excellent track record in providing services from pre-clinical to commercialization stage.

  • CN
  • 2023
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
  • 99 Haike Road, Building 3, 1st Floor, Pudong New District, Shanghai, China
Event information
CPHI & PMEC China 2024
  • 19 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand E3B26a, Finished Dosage